Company / Operating Income
Maze Therapeutics, Inc. Operating Income History
FY2025-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$142.9M
FY2025
5-year range
-$142.9M / -$142.9M
FY2025-FY2025
Trend
-
vs FY2024
Sector context
#111 of 204
Health Care
What the data says
At -$143M, Maze Therapeutics, Inc.'s operating income ranks #111 of 204 in the Health Care sector.
Based on SEC 10-K filings.
-$143M in FY2025.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#111 of 204 in Health CareTop 54% of 204This company -$142.9M Sector average $107.7M
▼
-232.7% below sector average
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$142.9M | - |
As of FY2025 · SEC 10-K · Updated Mar 29, 2026